{"id":"NCT02219477","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis","officialTitle":"An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-24","primaryCompletion":"2016-06-13","completion":"2017-03-03","firstPosted":"2014-08-19","resultsPosted":"2017-07-11","lastUpdate":"2017-07-11"},"enrollment":36,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C","Decompensated Cirrhosis","Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir","otherNames":["ABT-267 also known as ombitasvir","ABT-450 also known as paritaprevir","ritonavir also known as norvir"]},{"type":"DRUG","name":"dasabuvir","otherNames":["ABT-333"]},{"type":"DRUG","name":"ribavirin","otherNames":[]}],"arms":[{"label":"Group 1: GT1B","type":"EXPERIMENTAL"},{"label":"Group 2: GT1 Non-B","type":"EXPERIMENTAL"},{"label":"Group 3: GT4","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to assess the safety and the SVR12 rate of ombitasvir/paritaprevir/ritonavir and dasabuvir with RBV in GT1-infected participants with decompensated cirrhosis.","primaryOutcome":{"measure":"Percentages of Participants With Sustained Virologic Response 12 Weeks Post-Treatment (SVR12) in Group 1 and in Group 2","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"Group 1: GT1B","deltaMin":100,"sd":null},{"arm":"Group 2: GT1 Non-B","deltaMin":95.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":9},"commonTop":["NAUSEA","FATIGUE","DIARRHOEA","DIZZINESS","ASCITES"]}}